P

Insulet Corp
D

PODD

275.89
USD
2.99
(1.10%)
مغلق
حجم التداول
13,964
الربح لكل سهم
4
العائد الربحي
-
P/E
47
حجم السوق
19,352,241,975
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ABT
    ABT
    -0.420
    (-0.37%)
    113.490 USD
    BSX
    BSX
    0.463
    (0.47%)
    98.643 USD
    DXCM
    DXCM
    -0.440
    (-0.52%)
    84.360 USD
    EW
    EW
    -0.080
    (-0.11%)
    69.790 USD
    ISRG
    ISRG
    8.60
    (1.47%)
    592.67 USD
    MDT
    MDT
    0.920
    (1.06%)
    88.090 USD
    PFE
    PFE
    -0.195
    (-0.74%)
    26.305 USD
    T
    TFX
    -0.040
    (-0.02%)
    181.360 USD
    T
    TNDM
    -2.370
    (-6.31%)
    35.180 USD
    ZBH
    ZBH
    0.630
    (0.58%)
    109.560 USD
    المزيد
الأخبار
المقالات

العنوان: Insulet Corp

القطاع: Healthcare
الصناعة: Medical Devices
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.